Abstract
Indolo[2,3-d]benzazepines (indololatonduines) are rarely discussed in the literature. In this project, we prepared a series of novel indololatonduine derivatives and their RuII and OsII complexes and investigated their microtubule-targeting properties in comparison with paclitaxel and colchicine. Compounds were fully characterized by spectroscopic techniques (1H NMR and UV-vis), ESI mass-spectrometry, and X-ray crystallography, and their purity was confirmed by elemental analysis. The stabilities of the compounds in DMSO and water were confirmed by 1H and 13C NMR and UV-vis spectroscopy. Novel indololatonduines demonstrated anticancer activity in vitro in a low micromolar concentration range, while their coordination to metal centers resulted in a decrease of cytotoxicity. The preliminary in vivo activity of the RuII complex was investigated. Fluorescence staining and in vitro tubulin polymerization assays revealed the prepared compounds to have excellent microtubule-destabilizing activities, even more potent than the well-known microtubule-destabilizing agent colchicine.
| Original language | English |
|---|---|
| Pages (from-to) | 1456–1470 |
| Journal | Inorganic Chemistry |
| Volume | 61 |
| Issue number | 3 |
| Online published | 7 Jan 2022 |
| DOIs | |
| Publication status | Published - 24 Jan 2022 |
Research Keywords
- TUBULIN INHIBITORS
- KINASE INHIBITORS
- RESISTANCE
- COLCHICINE
- MORPHOLINE
- ANALOGS
- SOLUBILITY
- RUTHENIUM
- PAULLONES
- THERAPY
Publisher's Copyright Statement
- This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/